AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Tectonic Therapeutic management to participate in three investor conferences in September 2025.
ByAinvest
Thursday, Aug 28, 2025 9:04 am ET1min read
Tectonic Therapeutic, a clinical stage biotechnology company, announced management participation in three investor conferences in September 2025. The conferences include the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, and Morgan Stanley 23rd Annual Global Healthcare Conference. The company's CFO, Chief Business Officer, and CEO will participate in fireside chats at these events.
Tectonic Therapeutic, a clinical-stage biotechnology company, has announced its participation in three major investor conferences in September 2025. The company, which specializes in GPCR-focused therapeutic proteins and antibodies, will be represented by its CFO, Chief Business Officer, and CEO at the following events:1. Wells Fargo Healthcare Conference on September 3, featuring a fireside chat with CFO Daniel Lochner and CBO Marc Schwabish.
2. Cantor Global Healthcare Conference on September 4, with a fireside chat between CEO Alise Reicin and CFO Daniel Lochner.
3. Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, featuring a fireside chat with CEO Alise Reicin.
These live fireside chats will be available for replay on the company's website for approximately 90 days after the conferences. Additionally, the Tectonic management team will host one-on-one meetings during the three conferences. Interested investors are encouraged to contact their respective representatives at Wells Fargo, Cantor, and Morgan Stanley to schedule meetings.
Tectonic Therapeutic is headquartered in Watertown, Massachusetts, and focuses on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). The company leverages its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery) to develop biologic medicines that address significant unmet medical needs.
References:
[1] https://investors.tectonictx.com/stock-information
[2] https://www.stocktitan.net/news/TECX/tectonic-therapeutic-to-participate-in-september-investor-vt5xy84d7skj.html
[3] https://www.marketbeat.com/instant-alerts/filing-raymond-james-financial-inc-acquires-108668-shares-of-ssc-technologies-holdings-inc-ssnc-2025-08-21/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet